This evidence opens a new venue for the local treatment of BC through the instillation of rhDNaseI into the bladder to compensate for the DNaseI reduction, limit the NETosis in the tumor microenvironment and reduce the possibility of tumor progression and metastasis while reducing the risk of cancer-associated thrombosis in these patients. The gene discussed is DNASE1; the disease is neoplasm.